Type
1.
Stone C, Kastner R, Steinmann P, Chitnis N, Tanner M, Tediosi F. Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage. BMJ global health [Internet]. 2016;1:e000021. Available from: http://gh.bmj.com/content/bmjgh/1/1/e000021.full.pdf
Type
Custom 6
<p><a href="https://countdownonntds.wordpress.com/">https://countdownonntds.wordpress.com/</a></p>
Year of Publication
0
Type of Work
Blog
Publication Language
eng
Publisher
Countdown on NTDs
Citation Key
27637
Type
1.
Lymphoedema staff mannual: treatment and prevention of problems associated with lymphatic filariasis. [Internet]. Part 1. Learner’s Guide. Geneva: World Health Organization; 2001 p. 87 p. Available from: http://apps.who.int/iris/bitstream/10665/67224/1/WHO_CDS_CPE_CEE_2001.26a.pdf
Type
1.
Amnie A. An impact evaluation of two rounds of mass drug administration on the prevalence of trachoma in Plateau and Nasarawa States of Nigeria: A clustered cross sectional survey. [Internet]. Hubert Department of Global Health . [Atlanta]: Rollins School of Public Health; 2013. p. 65 p. Available from: http://pid.emory.edu/ark:/25593/d98mb
Type
1.
Strahm M. Assessing the impact of mass drug administration (MDA) in the Global Programme to Eliminate Lymphatic Filariasis (GPELF) on patients with filarial disease. [Internet]. Hubert Department of Global Health. [Atlanta]: Rollins School of Public Health; 2011. p. 72 p. Available from: http://pid.emory.edu/ark:/25593/bmfnj
Type
1.
Turner H, Truscott J, Fleming F, Hollingsworth D, Brooker S, Anderson R Imperial College of Science Technology and Medicine: Imperial College London. Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analyses. The Lancet. Infectious diseases [Internet]. 2016;16(7):838-46. Available from: http://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(15)00268-6.pdf
Type
1.
Higazi T, Geary T, Mackenzie C. Chemotherapy in the treatment, control, and elimination of human onchocerciasis. Research and Reports in Tropical Medicine [Internet]. 2014;2014(5):77-93. Available from: http://www.dovepress.com/research-and-reports-in-tropical-medicine-journalhttp://www.dovepress.com/chemotherapy-in-the-treatment-control-and-elimination-of-human-onchoce-peer-reviewed-article-RRTM
Type
1.
Kisoka W, Tersbøl BP, Meyrowitsch D, Simonsen P, Mushi D. Community members’ perceptions of mass drug administration for control of lymphatic filariasis in rural and urban Tanzania. Journal of biosocial science. 2015;:1-19.
Type
1.
Hotez P, Velasquez R, Wolf J. Neglected tropical skin diseases: their global elimination through integrated mass drug administration? JAMA dermatology. 2014;150(5):481-2.
Type
1.
Jenson A, Gracewello C, Mkocha H, Roter D, Munoz B, West S. Gender and performance of community treatment assistants in Tanzania. International Journal for Quality in Health Care [Internet]. 2014;26(5):524-9. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490229/pdf/mzu067.pdf